P.J. represents medical device and pharmaceutical manufacturers in pattern litigation or mass torts (particularly “multidistrict litigation”), and in “one-off” product liability suits, serving as national coordinating and trial counsel in both large, complex matters, and individual cases. He has defended toxic and environmental exposure suits, and also defends individuals and companies in alleged class actions and complex business litigation, particularly with regard to claims of fiduciary breaches, consumer fraud, deceptive practices, and professional negligence.
P.J. has been a key member of trial teams in high-profile litigation, and actively manages all stages of pretrial proceedings. He has significant experience defending and examining corporate and expert witnesses in various fields, including industry specific standards of care, regulatory affairs, medical causation, surgical technique, materials science, toxicology, internal medicine, and economic losses. This experience extends beyond the deposition stage, where he designs and implements strategies to exclude (or limit) expert testimony through motions practice or evidentiary hearings pursuant to Daubert, Kemp, Havner/Robinson, and similar admissibility standards. P.J. has briefed and argued dispositive motions and appeals in state and federal trial and appellate courts throughout the country. In addition, he has conducted arbitrations and mediations dealing with a host of disputes.
P.J. is active in local and state bar associations, and frequently presents publicly and privately on product liability issues, recently covering such issues as the Biomaterials Access Assurance Act, supply chain liability, and other matters pertinent to defense of medical device and pharmaceutical firms (such as federal preemption). In March 2013, he spoke at HarrisMartin’s Mass Tort Litigation Conference on the topic of recent changes to the Federal Rules of Civil Procedure concerning disclosure requirements for non-retained treating physicians. He is currently participating in the The Sedona Conference® Working Group on Mass Torts and Punitive Damages. To further his understanding of the issues facing his clients in the life sciences industry, P.J. has been a member of the Regulatory Affairs Professional Society since 2011, and he is active in BioOhio, a non-profit intended to build and accelerate the bioscience industry. P.J. was selected by his peers for inclusion in The Best Lawyers in America® in the Product Liability Litigation field, has been recognized as a “Future Star” by Benchmark Litigation, and has been named to the Ohio Super Lawyers Rising Stars list.
(LL.M., Trial Advocacy)